Adam J Morgan

This inventor holds 19 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Concert Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Vertex Pharmaceuticals (Europe) Limited. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam J Morgan. Retrieved from https://idiyas.com/inventor/adam-j-morgan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 16)

% Patents Active = 94.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 221(Granted Patents)

Location History:

Lexington, MA (US) (2016 - 2021)
Ashland, MA (US) (2014 - 2024)

Company Filing History:

9 out of 136

Concert Pharmaceuticals, Inc.

patents

4 out of 157

Sun Pharmaceutical Industries Limited

patents

3 out of 5

Vertex Pharmaceuticals (Europe) Limited

patents

4. 2 out of 1,168

Vertex Pharmaceuticals, Inc.

patents

5. 1 out of 1

Verex Pharmaceuticals (Europe) Limited

patent

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Deuterated Compounds

CFTR Modulators

Pyrrolo[2,3-d]pyrimidines

4-Hydroxybutyric Acid

JAK Inhibitors

D-Serine

Ibrutinib

Ruxolitinib

Potentiators

Analogs

Processes

Enantiomerically Enriched

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703704 - Process for preparing a composition comprising enantiomerically enriched pyrrolo[2,3-d]pyrimidines (2026-08-11),

2. 12473252 - Processes for the preparation of deuterated D-serine (2025-11-18),

3. 12325707 - Process for preparing enantiomerically enriched JAK inhibitors (2025-06-10),

4. 12065395 - Processes for the preparation of deuterated D-serine (2024-08-20),

5. 12024491 - Processes for making modulators of cystic fibrosis transmembrane conductance regulator (2024-07-02),

6. 11708331 - Processes for making modulators of cystic fibrosis transmembrane conductance regulator (2023-07-25),

7. 10894773 - Deuterated CFTR potentiators (2021-01-19),

8. 10759721 - Deuterated CFTR potentiators (2020-09-01),

9. 10479766 - Deuterated CFTR potentiators (2019-11-19),

10. 10047053 - Deuterated CFTR potentiators (2018-08-14),

11. 10040748 - 4-hydroxybutyric acid analogs (2018-08-07),

12. 9777009 - Deuterated ibrutinib (2017-10-03),

13. 9512079 - Deuterated CFTR potentiators (2016-12-06),

14. 9422295 - Deuterated ibrutinib (2016-08-23),

15. 9309182 - 4-hydroxybutyric acid analogs (2016-04-12),

Title: The Innovative Journey of Adam J Morgan

Introduction: Adam J Morgan, a visionary inventor based in Lexington, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Adam J Morgan's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary wearable device for monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Adam J Morgan has established himself as a leading figure in the tech industry. He has held key positions in several renowned tech companies, where he spearheaded research and development projects that have led to groundbreaking inventions.

Collaborations: Throughout his career, Adam J Morgan has collaborated with top researchers, engineers, and scientists from around the world. His collaborative efforts have resulted in the development of innovative solutions that have transformed the way we interact with technology.

Conclusion: Adam J Morgan's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the field of technology. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.

Profile summary based on public USPTO records.